ArticleCurrent infectious disease reports2005
Global trends in candidemia: review of reports from 1995-2005.
Article in Current infectious disease reports, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 133 citations in OpenAlex.
- Fungal Pericarditis-A Systematic Review of 101 Cases.Microorganisms · 2025Review
- Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole againstFrontiers in microbiology · 2024Article
- Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis.PLoS biology · 2022Article
- Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities.Microbiome · 2021Review
- Review
- Thoughts on the evolution of Core Environmental Responses in yeasts.Fungal biology · 2020Article
- Deletion of the fungus specific protein phosphatase Z1 exaggerates the oxidative stress response in Candida albicans.BMC genomics · 2019Article
- The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019Article
- Effectiveness of Phytoactive Molecules on Transcriptional Expression, Biofilm Matrix, and Cell Wall Components ofACS omega · 2018Article
- Article
- Antifungal Drug Susceptibility ofFrontiers in microbiology · 2017Article
- Enhanced Killing and Antibiofilm Activity of Encapsulated Cinnamaldehyde againstFrontiers in microbiology · 2017Article
- Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis.PLoS genetics · 2016Article
- Pho4 mediates phosphate acquisition in Candida albicans and is vital for stress resistance and metal homeostasis.Molecular biology of the cell · 2016Article
- Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.Mycopathologia · 2015Article
- Emergence of azole-resistantCurrent medical mycology · 2015Article
- Candida species bloodstream infections in hospitalised children: A 10-year experience.Journal of paediatrics and child health · 2015Article
- Oxidative stress responses in the human fungal pathogen, Candida albicans.Biomolecules · 2015Review
- Potential Use of Phenolic Acids as Anti-Candida Agents: A Review.Frontiers in microbiology · 2015Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Candida species are an important cause of health care-related bloodstream infections (BSI). Understanding the current Candida BSI incidence trends, the dominant species causing disease, and the mortality associated with this infection are important to help guide therapeutic and prophylaxis measures. In this review, trends in the incidence of Candida BSI are assessed using data extracted from reports published worldwide during 1995 to 2005. The incidence trend of Candida BSI was found to be stable for most of the reports reviewed, and Candida albicans remains the most common species causing Candida BSIs. Surveillance to monitor the burden of disease and emergence of resistance, among the general patient population and among high risk patient populations, should be continued.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.